Published in Mod Rheumatol on January 01, 2006
Clinical characteristics of idiopathic portal hypertension. World J Gastroenterol (2007) 0.88
Is spleen circulation impaired in systemic sclerosis and what is the role of liver fibrosis? World J Gastroenterol (2011) 0.82
Life-threatening hypersplenism due to idiopathic portal hypertension in early childhood: case report and review of the literature. BMC Gastroenterol (2010) 0.76
Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab. Ann Rheum Dis (2007) 4.05
Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum (2004) 3.92
Induction of triggering receptor expressed on myeloid cells 1 in murine resident peritoneal macrophages by monosodium urate monohydrate crystals. Arthritis Rheum (2006) 1.73
Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis. Arthritis Res Ther (2004) 1.29
Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis. Curr Opin Rheumatol (2007) 1.19
Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis. Mod Rheumatol (2009) 1.13
Potential roles of microsomal prostaglandin E synthase-1 in rheumatoid arthritis. Inflamm Regen (2011) 1.11
Inhibition of monosodium urate monohydrate crystal-induced acute inflammation by retrovirally transfected prostaglandin D synthase. Arthritis Rheum (2003) 1.04
Efficacy and safety of tacrolimus for lupus nephritis: a placebo-controlled double-blind multicenter study. Mod Rheumatol (2009) 1.03
Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors. Arthritis Rheum (2002) 1.02
Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells. J Rheumatol (2002) 1.01
Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts. Arthritis Rheum (2003) 1.00
Prostaglandin E synthase in the pathophysiology of arthritis. Fundam Clin Pharmacol (2005) 0.99
Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells. FEBS Lett (2002) 0.99
Adiponectin stimulates prostaglandin E(2) production in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum (2010) 0.98
Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis. Intern Med (2011) 0.97
Adiponectin stimulates IL-8 production by rheumatoid synovial fibroblasts. Biochem Biophys Res Commun (2008) 0.96
Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan. Clin Rheumatol (2012) 0.92
Prostaglandin E2 differentially modulates proinflammatory/prodestructive effects of TNF-alpha on synovial fibroblasts via specific E prostanoid receptors/cAMP. J Immunol (2009) 0.91
Prostaglandin E2 production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not cyclooxygenase-2. Prostaglandins Leukot Essent Fatty Acids (2005) 0.89
Serum adipokine profiles in Kawasaki disease. Mod Rheumatol (2011) 0.88
Retrovirally introduced prostaglandin D2 synthase suppresses lung injury induced by bleomycin. Am J Respir Cell Mol Biol (2003) 0.87
Prostaglandin E2 activates Rap1 via EP2/EP4 receptors and cAMP-signaling in rheumatoid synovial fibroblasts: involvement of Epac1 and PKA. Prostaglandins Other Lipid Mediat (2009) 0.86
Post-marketing surveillance of the safety and effectiveness of tacrolimus in 3,267 Japanese patients with rheumatoid arthritis. Mod Rheumatol (2014) 0.85
Antiinflammatory effect of retrovirally transfected interleukin-10 on monosodium urate monohydrate crystal-induced acute inflammation in murine air pouches. Arthritis Rheum (2002) 0.85
Therapeutic effects of the combination of methotrexate and bucillamine in early rheumatoid arthritis: a multicenter, double-blind, randomized controlled study. Mod Rheumatol (2005) 0.85
Optimum formulation for sustained-release insulin. Int J Pharm (2004) 0.84
A novel celecoxib derivative potently induces apoptosis of human synovial fibroblasts. J Pharmacol Exp Ther (2005) 0.83
Exacerbation of adult-onset Still's disease, possibly related to elevation of serum tumor necrosis factor-alpha after etanercept administration. Int J Rheum Dis (2010) 0.83
Tacrolimus therapy for systemic lupus erythematosus without renal involvement: a preliminary retrospective study. Mod Rheumatol (2009) 0.83
Assessing the cardiovascular risk between celecoxib and nonselective nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis and osteoarthritis. Circ J (2013) 0.82
Major enzymatic pathways in dermal wound healing: current understanding and future therapeutic targets. Curr Opin Investig Drugs (2006) 0.81
Resistin is associated with the inflammation process in patients with systemic autoimmune diseases undergoing glucocorticoid therapy: comparison with leptin and adiponectin. Mod Rheumatol (2012) 0.81
Nonsteroidal anti-inflammatory drugs induce apoptosis in association with activation of peroxisome proliferator-activated receptor gamma in rheumatoid synovial cells. J Pharmacol Exp Ther (2002) 0.81
Pharmacokinetic and pharmacodynamic interactions between simvastatin and diltiazem in patients with hypercholesterolemia and hypertension. Life Sci (2004) 0.80
Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials. Mod Rheumatol (2014) 0.80
Triptolide, an active compound identified in a traditional Chinese herb, induces apoptosis of rheumatoid synovial fibroblasts. BMC Pharmacol (2004) 0.80
Pharmacokinetic study and Fcgamma receptor gene analysis in two patients with rheumatoid arthritis controlled by low-dose infliximab. Mod Rheumatol (2009) 0.80
Celecoxib prevents juxta-articular osteopenia and growth plate destruction adjacent to inflamed joints in rats with collagen-induced arthritis. Mod Rheumatol (2007) 0.79
Preliminary study to identify the predictive factors for the response to methotrexate therapy in patients with rheumatoid arthritis. Yakugaku Zasshi (2009) 0.79
Changes of serum soluble receptor activator for nuclear factor-κB ligand after glucocorticoid therapy reflect regulation of its expression by osteoblasts. J Clin Endocrinol Metab (2012) 0.79
Weekly pulse therapy of methotrexate improves survival compared with its daily administration in MRL/lpr mice. Eur J Pharmacol (2002) 0.79
Plasma leptin levels in patients with burn injury: a preliminary report. Burns (2003) 0.78
Leptin stimulates interleukin-6 production via janus kinase 2/signal transducer and activator of transcription 3 in rheumatoid synovial fibroblasts. Clin Exp Rheumatol (2013) 0.78
Systemic lupus erythematosus complicated by recurrent pneumothorax: Case report and literature review. Nihon Rinsho Meneki Gakkai Kaishi (2010) 0.78
Inhibition of skin sclerosis by 15deoxy delta12,14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma. Biomed Pharmacother (2005) 0.78
A celecoxib derivative potently inhibits proliferation of colon adenocarcinoma cells by induction of apoptosis. Anticancer Res (2006) 0.77
[Mechanisms and therapeutics of glucocorticoid-induced osteoporosis]. Nihon Rinsho Meneki Gakkai Kaishi (2011) 0.77
Pro-apoptotic effect of nonsteroidal anti-inflammatory drugs on synovial fibroblasts. Mod Rheumatol (2008) 0.77
New insights into eicosanoid biosynthetic pathways: implications for arthritis. Expert Rev Clin Immunol (2006) 0.77
Aspirin and sodium salicylate inhibit proliferation and induce apoptosis in rheumatoid synovial cells. J Pharm Pharmacol (2002) 0.77
Clinical activity after 12 weeks of treatment with nonbiologics in early rheumatoid arthritis may predict articular destruction 2 years later. J Rheumatol (2010) 0.76
Pharmacokinetics and pharmacodynamics of low doses of midazolam administered intravenously and orally to healthy volunteers. Clin Exp Pharmacol Physiol (2009) 0.76
Allylation reactions of aldehydes with allylboronates in aqueous media: unique reactivity and selectivity that are only observed in the presence of water. Chem Asian J (2013) 0.76
Safety profile of tacrolimus in patients with rheumatoid arthritis. Clin Rheumatol (2008) 0.76
Altered pharmacokinetics and excessive hypotensive effect of candesartan in a patient with the CYP2C91/3 genotype. Clin Pharmacol Ther (2003) 0.75
[Systemic autoimmune diseases]. Nihon Rinsho (2008) 0.75
[Diagnosis and therapy for polymyositis and dermatomyositis]. Nihon Naika Gakkai Zasshi (2007) 0.75
Efficacy of Vitamin K2 for Glucocorticoid-induced Osteoporosis in Patients with Systemic Autoimmune Diseases. Intern Med (2016) 0.75
[Two severe tetanus cases infected in an urban area of Kawasaki City]. Kansenshogaku Zasshi (2009) 0.75
[Nonsteroidal anti-inflammatory drugs and glucocorticoids for treatment of connective tissue diseases]. Nihon Rinsho (2009) 0.75
Prevention of joint destruction by tacrolimus in patients with early rheumatoid arthritis: a post hoc analysis of a double-blind, randomized, placebo-controlled study. Mod Rheumatol (2012) 0.75
Erythrocyte methotrexate-polyglutamate assay using fluorescence polarization immunoassay technique: application to the monitoring of patients with rheumatoid arthritis. Yakugaku Zasshi (2009) 0.75
Brain-derived neurotrophic factor bound with lecithin derivative showed a markedly enhanced pharmacological potency due to its potent cell membrane affinity followed by prolonged MAPK activation. J Control Release (2005) 0.75
Tacrolimus down-regulates chemokine expressions on rheumatoid synovial fibroblasts: screening by a DNA microarray. Inflamm Res (2012) 0.75
[Progress in chemotherapy of rheumatoid arthritis]. Nihon Naika Gakkai Zasshi (2004) 0.75
[Relationship between serum uric acid levels and muscle strength/volume: a new insight from a large-scale survey]. Nihon Jinzo Gakkai Shi (2014) 0.75
[Bevacizumab-Related Hyperintense Lesions on Diffusion-Weighted Imaging at Different Locations in a Patient with Malignant Glioma]. No Shinkei Geka (2017) 0.75
[Emergence of new therapeutic agents for collagen diseases and some of the problems]. Nihon Naika Gakkai Zasshi (2003) 0.75
[Glucocorticoid and Bone. Significance of serum soluble RANKL measurement in patients under glucocorticoid therapy]. Clin Calcium (2014) 0.75